Chica-Parrado MR, Kim GM, Uemoto Y, Napolitano F, et al. Combined inhibition of CDK4/6 and AKT is highly effective against the luminal androgen receptor (LAR) subtype of triple negative breast cancer. Cancer Lett 2024 Sep 5:217219. doi: 10.1016/j.canlet.2024.217219.
PMID: 39244005